Clinical Trials in Houston

Showing 10701-10720 of 17,885 trials

Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

NCT03887429

The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 or placebo when dosed for 5 days in adults with tobacco use disorder who voluntarily abstain from the use of cigarettes.

Impulse Control Disorders

Promentis Pharmaceuticals, Inc.34 participantsStarted Mar 2019

Lincoln, Nebraska, United States • Houston, Texas, United States

TERMINATEDPhase 3< 1 mile

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

NCT03114657

This randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild AD. Participants will be randomized 1:1 to receive either intravenous (IV) infusion of crenezumab or placebo every 4 weeks (Q4W) for 100 weeks. The primary efficacy assessment will be performed at 105 weeks. The participants who do not enter open-label extension will enter for a long term follow-up period for up to 52 weeks after the last crenezumab dose (Week 153).

Alzheimer's Disease

Hoffmann-La Roche806 participantsStarted Mar 2017

Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States • Little Rock, Arkansas, United States +208 more locations

Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

Find Trials by Condition in Houston

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer

Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer

Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery

Visual Outcomes for Toric Efficacy Study

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder

Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.

The Effects of a Life Coaching Seminar on Gratitude and Psychological Well-Being